CLT20 - Anti-Doping Policy

Anti-Doping Policy

A	CLT20 fully supports the prevention of Doping in sport generally.
B	This Anti-Doping Code extends to all Cricketers who participate in Matches.
C	It shall be the responsibility of each Team who competes in the League to ensure that all Cricketers who represent such Teams are aware of, and knowledgeable about, this Anti-Doping Code.

1. Interpretation

1.1. Definitions

Adverse Analytical Finding
means a report from a WADA-Accredited Laboratory or other WADA-approved entity that, consistent with the International Standard for Laboratories, identifies in a Sample the presence of a Prohibited Substance or its Metabolites or Markers (including elevated quantities of endogenous substances) or evidence of the Use of a Prohibited Method.

Anti-Doping Code
means this code, the policies and regulations contained herein and all Schedules hereto.

Anti-Doping Code Violation
means a breach of this Anti-Doping Code pursuant to Clause 3.1 to Clause 3.8.

Anti-Doping Organisation
means CLT20 and any other entity designated by CLT20 as possessing the authority and responsibility to conduct Doping Control in relation to the League. Such entity or entities shall be designated with the primary authority and responsibility to implement this Anti-Doping Code for Matches.

Attempt
means purposely engaging in conduct that constitutes a substantial step in a course of conduct planned to culminate in the commission of an Anti-Doping Code Violation provided, however, there shall be no Anti-Doping Code Violation based solely on an attempt to commit an Anti-Doping Code Violation if the Cricketer renounces the attempt prior to it being discovered by a third party not involved in the attempt.

Atypical Finding
means a report from a WADA-Accredited Laboratory or other WADA-approved entity that requires further investigation as provided by the International Standard for Laboratories prior to the determination of an Adverse Analytical Finding.

CAS
means the Court of Arbitration for Sport.

CLT20
means the Champions League Twenty20. CLT20 is Sub-Committee of the Board of Control for Cricket in India which has been established to own and oversee the operation of the League via its Governing Council.

Cricketer
means the Cricket Players and the Cricket Support Personnel involved in playing, organizing, administering or governing cricket for one of the Teams participating in the League.

Cricket Player
means a person who participates (whether In-Competition or Out-of-Competition) as a player in any Team.

Cricket Support Personnel
means an agent or employee of each Team participating in the League working with or treating Cricket Players participating in or preparing for any Matches or any other person who administers, manages, assists or is otherwise involved in or associated with a Team in respect of the League.

Doping
means the occurrence of one or more of the Anti-Doping Code Violations.

Doping Control
means all steps and processes from test distribution planning through to ultimate disposition of any appeal including all steps and processes in between such as Sample collection and handling, laboratory analysis, Therapeutic Use Exemptions, results management, hearings and appeals.

Drugs Appeal Tribunal
means the appeal tribunal established and constituted in accordance with this Anti-Doping Code by CLT20 to hear appeals from any decision of the Drugs Tribunal.

Drugs Tribunal
means the tribunal established and constituted in accordance with this Anti-Doping Code by CLT20, to investigate and conduct hearings in relation to alleged Anti-Doping Code Violations, and to impose sanctions in respect thereof.

Home Board
means the domestic or local governing body for cricket in the Cricketer's home country or territory.

In-Competition
in respect of a Team means each day during a Season on which that Team plays a Match.

Independent Observers
means a team of not more than three observers under the supervision of WADA or such other Anti-Doping Organisation and approved by CLT20, who may observe the Doping Control process at the relevant Match and shall report their observations to WADA, or the Anti-Doping Organisation, and CLT20.

Ineligibility/Suspension
means that the Cricketer shall be barred for a specific period of time from participating in any capacity in any event or activity (other than authorised anti-doping education or rehabilitation programs and any events or activities relating to the Cricketer's achievements prior to his or her Anti-Doping Code Violation) authorised or organised by CLT20 during the relevant Ineligibility period. A non-exhaustive list of some of the preclusions can be found at clause 9.12 of this Anti-Doping Code.

International Standard
means a standard adopted by WADA in support of the WADA Code. Compliance with an International Standard (as opposed to another alternative standard, practice or procedure) shall be sufficient to conclude that the procedures addressed by the International Standard were performed properly. International Standards shall include any Technical Documents issued pursuant to the International Standard.

League
means the Twenty20 cricket league (known as Champions League Twenty20) which has been established by CLT20.

Marker
means a compound, group of compounds or biological parameter(s) that indicates the Use of a Prohibited Substance or a Prohibited Method.

Match
means each League match played between Teams.

Medical Committee
means a committee of three medical experts established and constituted by CLT20, to advise CLT20 on medical issues in connection with the League and to perform such other functions as CLT20 may direct including dealing with applications for Therapeutic Use Exemptions.

Metabolite
means any substance produced by a biotransformation process.

No Fault or Negligence
means a Cricketer establishing that he did not know or suspect and could not reasonably have known or suspected even with the exercise of utmost caution, that he had Used or been administered the Prohibited Substance or Prohibited Method.

No Performance Enhancing Effect
means the Cricketer establishing that the Prohibited Substance or its Markers or Metabolite detected in his Sample had no performance enhancing effect at all and could not have been used at all to mask a performance enhancing substance.

No Significant Fault or Negligence
means a Cricketer establishing that his fault or negligence, when viewed in totality of the circumstances and taking into account the criteria for No Fault or Negligence, was not significant in relation to the Anti-Doping Code Violation.

Out-of-Competition
in respect of a Team means the period during the Season other than days on which that Team plays a Match.

Possession
means the actual, physical possession or the constructive possession (which shall be found only if the person has exclusive control over the Prohibited Substance/Prohibited Method or the premises in which a Prohibited Substance/Prohibited Method exists) provided, however, that if the person does not have exclusive control over the Prohibited Substance/Prohibited Method or the premises in which a Prohibited Substance/Prohibited Method exists, constructive possession shall only be found if the person knew about the presence of the Prohibited Substance/Prohibited Method and intended to exercise control over it. Provided, however, there shall be no Anti-Doping Code Violation based solely on possession if, prior to receiving notification of any kind that the Cricketer committed an Anti-Doping Code Violation, the Cricketer has taken concrete action demonstrating that the Cricketer never intended to have possession and has renounced possession by explicitly declaring it to CLT20 or another Anti-Doping Organisation. Notwithstanding anything to the contrary in this definition, the purchase (including by any electronic or other means) of a Prohibited Substance or Prohibited Method constitutes possession by the person who makes the purchase.

Prohibited List
means the then-current WADA Prohibited List identifying the Prohibited Substances and Prohibited Methods. This list is updated annually by WADA and further information can be found at the WADA website www.wada.ama.org.

Prohibited Method
means any method so described on the Prohibited List.

Prohibited Substance
means any substance so described on the Prohibited List.

Provisional Suspension
means an immediate suspension imposed on a Cricketer in accordance with clause 8.4.2.

Sample/Specimen
means any biological substance collected from a Cricketer for the purpose of Doping Control.

Season
shall mean the period of time in each year during which the League shall take place (which shall include the Support Period).

Specified Substance
means substances identified as specified substances in the Prohibited List.

Spurious or Frivolous
means that, on reasonable grounds, the appeal was made in bad faith or for a purpose other than to obtain access to a proper appeal on the merits or to abuse the Doping Control process.

Substantial Assistance
For the purpose of clause 9.5.3, a person providing Substantial Assistance must: (a) fully disclose in a signed written statement all information he possesses in relation to Anti-Doping Code Violations, and (b) fully cooperate with the investigation and adjudication of any case related to that information, including, for example, presenting testimony at a hearing if requested to do so by an Anti-Doping Organisation or to CLT20. Further, the information provided must be credible and must comprise an important part of any case which is initiated or, if no case is initiated, must have provided a sufficient basis on which a case could have been brought.

Support Period
means, in respect of each Cricket Player, the period commencing three (3) full days prior to the day on which the first Match is played by the Cricket Player in the relevant Season and ending one (1) full day after the day on which the last Match is played by the Cricket Player in the relevant Season.

Tampering
means altering for an improper purpose or in an improper way, bringing improper influence to bear, interfering improperly, obstructing, misleading or engaging in fraudulent conduct to alter results or prevent normal procedures from occurring or providing fraudulent information to an Anti-Doping Organisation or to CLT20.

Target Testing
means selection of Players for Testing where specific Players or groups of Players are selected on a non-random basis for Testing at a specified time.

Team
means the team of players representing the entity which has been granted the right to own and operate a CLT20 team in any Match.

Testing
means the parts of the Doping Control process involving test distribution planning, Sample collection, Sample handling, and Sample transport to a WADA-Accredited Laboratory.

Therapeutic Use Exemption
means an exemption granted by the Medical Committee pursuant to clause 5.3 of this Anti-Doping Code;

Trafficking
means selling, giving, transporting, sending, deliver by or distributing a Prohibited Substance or Prohibited Method (either physically or by any electronic or other means) by a Cricketer to any third party provided, however, this definition shall not include the actions of bona fide medical personnel involving a Prohibited Substance used for genuine and legal therapeutic purposes or other acceptable justification , and shall not include actions involving Prohibited Substances which are not prohibited in Out-of-Competition Testing unless the circumstances as a whole demonstrate such Prohibited Substances are not intended for genuine and legal therapeutic purposes.

Use
means the utilization, application, ingestion, injection or consumption by any means whatsoever of any Prohibited Substance or Prohibited Method and has a corresponding meaning when used as a verb.

WADA
means the World Anti-Doping Agency.

WADA Accredited Laboratory
means a laboratory accredited by the WADA as qualified to undertake the detection of the presence or Use of Prohibited Substances and Prohibited Methods.

WADA Anti-Doping Code
(WADA Code) means the World Anti-Doping Agency Anti-Doping Code promulgated by the World Anti-Doping Agency (as amended from time to time).

1.2. Rules of interpretation

In this Anti-Doping Code, unless a contrary intention clearly appears, words importing:

1.2.1.	the singular shall include the plural and vice versa;
1.2.2.	any one gender includes the other gender; and
1.2.3.	any reference to an enactment, charter, or publication includes any amendment, re-enactment or republication thereof from time to time.

1.3. Statute of Limitation

No action may be commenced under this Anti-Doping Code against a Cricketer unless such action is commenced within eight years from the date the alleged Anti-Doping Code Violation is asserted to have occurred.

2 Obligations

2.1.

Cricketers' Obligations

2.1.1

It is the personal responsibility of Cricketers to be knowledgeable of and comply with the terms of this Anti-Doping Code.

2.1.2

In the context of anti-doping, Cricket Players take responsibility for:

a	what they ingest, Use and Possess; versa;
b	informing their medical personnel of the Cricket Players' obligations not to use Prohibited Substances and Prohibited Methods;
c	making sure that any medical treatment received by them does not violate this Anti-Doping Code; and
d	compliance with the testing protocol outlined in Schedule 3.

2.2 Obligations and Powers of CLT20

Under this Anti-Doping Code CLT20 shall (without limitation to any other provision of this Anti-Doping Code):

2.2.1	permit and assist the relevant Anti-Doping Organisation to attend matches in a Season (which includes warm up matches) conducted as part of the League by any of the participating Teams, in order to obtain Samples for testing for any Anti-Doping Code Violation;
2.2.2	notify Cricket Players that they are liable for selection to provide Samples for testing for any Anti-Doping Code Violation; and
2.2.3	arrange for the completion and return of any forms required for the purposes of the relevant Anti-Doping Organisation at the request of the relevant Anti-Doping Organisation.
2.3	CLT20 shall provide access to Independent Observers at Matches as directed by CLT20.
2.4	The costs for Testing and for administration of this Anti-Doping Code shall be borne by CLT20.

3. Anti-Doping Code Violations

Cricket Players and other persons shall be responsible for knowing what constitutes an Anti-Doping Code Violation and the Prohibited Substances and Prohibited Methods which have been included on the Prohibited List.

The following constitute Anti-Doping Code Violations:

3.1

The presence of a Prohibited Substance or its Metabolites or Markers in a Cricket Player's Sample.

3.5.1	It is each Cricket Player's personal duty to ensure that no Prohibited Substance enters his body. Cricket Players are responsible for any Prohibited Substance or its Metabolites or Markers found to be present in their Samples. Accordingly, subject to Clause 9.5, it is not necessary that intent, fault, negligence or knowing Use on the Cricket Player's part be demonstrated in order to establish an Anti-Doping Code Violation under Clause 3.1.
3.5.2	Sufficient proof of an Anti-Doping Code Violation under Clause 3.1 is established by either of the following: presence of a Prohibited Substance or its Metabolites or Markers in the Cricket Player's A Sample where the Cricket Player waives analysis of the B Sample and the B Sample is not analysed; or, where the Cricket Player's B Sample confirms the presence of the Prohibited Substance or its Metabolites or Markers found in the Cricket Player's A Sample.
3.5.3	Excepting those substances for which a quantitative reporting threshold is specifically identified in the Prohibited List, the detected presence of any quantity of a Prohibited Substance or its Metabolites or Markers in a Cricket Player's Sample shall constitute an Anti-Doping Code Violation.
3.1.4	As an exception to the general rule of Clause 3.1, the Prohibited List may establish special criteria for the evaluation of Prohibited Substances that can also be produced endogenously.

3.2

Use or Attempted Use of a Prohibited Substance or a Prohibited Method.

3.2.1	It is each Cricket Player's personal duty to ensure that no Prohibited Substance enters his body. Accordingly, it is not necessary that intent, fault, negligence or knowing Use on the Cricket Player's part be demonstrated in order to establish an Anti-Doping Code Violation under Clause 3.2.
3.2.2	The success or failure of the Use of a Prohibited Substance or Prohibited Method is not material. It is sufficient that the Prohibited Substance or Prohibited Method was Used or Attempted to be Used for an Anti-Doping Code Violation to be committed.

3.4

Tampering or Attempted Tampering with any part of Doping Control.

3.5

Possession of Prohibited Substances or Prohibited Methods.

3.5.1

This Clause applies to Possession by a Cricket Player In-Competition of any Prohibited Substance or Prohibited Method, or Possession by a Cricket Player Out-of-Competition of any Prohibited Substance or Prohibited Method which is prohibited Out-of-Competition unless the Cricket Player establishes that the Possession is pursuant to a Therapeutic Use Exemption granted in accordance with Clause 5.3 (Therapeutic Use) or other acceptable justification.

3.5.2

This Clause applies to Possession by Cricket Support Personnel In-Competition of any Prohibited Substance or any Prohibited Method or Possession by Cricket Support Personnel Out-of-Competition of any Prohibited Substance or any Prohibited Method which is prohibited Out-of-Competition in connection with a Cricket Player, Match or training, unless the Cricket Support Personnel establishes that the Possession is pursuant to a Therapeutic Use Exemption granted to a Cricket Player in accordance with Clause 5.3 (Therapeutic Use) or other acceptable justification.

3.6

Trafficking in any Prohibited Substance or Prohibited Method.

3.7

Administration or Attempted administration to any Cricket Player In-Competition of any Prohibited Substance or Prohibited Method, or administration or Attempted administration to any Cricket Player Out-of-Competition of any Prohibited Substance or Prohibited Method that is prohibited Out-of-Competition, or assisting, encouraging, aiding, abetting, covering up or any other type of complicity involving an Anti-Doping Code Violation or any Attempted Anti-Doping Code Violation.

4 Proof Of Doping

4.1	Burdens and Standards of Proof
	CLT20 shall have the burden of establishing that an Anti-Doping Code Violation has occurred. The standard of proof shall be whether CLT20 has established an Anti-Doping Code Violation to the comfortable satisfaction of the hearing body bearing in mind the seriousness of the allegation which is made. This standard of proof in all cases shall be greater than a mere balance of probabilities but less than a standard of proof of beyond a reasonable doubt. Where this Anti-Doping Code places the burden of proof upon the Cricketer alleged to have committed an Anti-Doping Code Violation to rebut a presumption or establish specified facts or circumstances, the standard of proof shall be on the balance of probabilities.
4.2	Methods of Establishing Facts and Presumptions
	Facts related to Anti-Doping Code Violations may be established by any reliable means, including admissions. The following rules of proof shall be applicable in Doping cases:

4.2.1	WADA Accredited Laboratories are presumed to have conducted Sample analysis and custodial procedures in accordance with the International Standard for Laboratories. The Cricket Player or other person may rebut this presumption by establishing that a departure from the International Standard for Laboratories occurred which could reasonably have cause the Adverse Analytical Finding.
	If the Cricket Player or other person rebuts the preceding presumption by showing that a departure from the International Standard for Laboratories occurred, then CLT20 shall have the burden to establish that such departure did not cause the Adverse Analytical Finding.
4.2.2	Departures from any other International Standard or other anti-doping rule which did not cause an Adverse Analytical Finding or other Anti-Doping Code Violation shall not invalidate such results. If the Cricket Player establishes that a departure from another International Standard or other anti-doping rule which could reasonably have caused the Adverse Analytical Finding occurred during testing then CLT20 shall have the burden to establish that such departure did not cause the Adverse Analytical Finding or the factual basis for the Anti-Doping Code Violation.
4.2.3	The facts established by a decision of a court or professional disciplinary tribunal of competent jurisdiction which is not the subject of a pending appeal shall be irrebuttable evidence against the Cricket Player or other person to whom the decision pertained of those facts unless the Cricket Player or other person establishes that the decision violated principles of natural justice.
4.2.4	The Drugs Tribunal in a hearing on an Anti-Doping Code Violation may draw an inference adverse to the Cricket Player or other person who is asserted to have committed an Anti-Doping Code Violation based on the Player or other person's refusal, after a request made in a reasonable time in advance of the hearing, to appear at the hearing (either in person or by telephone as directed by the tribunal) and to answer questions from the Drugs Tribunal or party asserting the Anti-Doping Code Violation.

5 The Prohibited List

5.1

Incorporation of the WADA Prohibited List

This Anti-Doping Code shall incorporate the Prohibited List as published by WADA and as amended from time to time. All Cricketers shall be bound by any changes to the Prohibited List provided CLT20 has taken reasonable steps to bring the amended Prohibited List to the attention of Teams and Cricketers. For the avoidance of doubt, the inclusion of the amended Prohibited List on the CLT20 Official Website accompanied by a note alerting Teams to the amendment shall be deemed to satisfy the preceding sentence.

5.2

Criteria for Including Substances and Methods on the Prohibited List

WADA's determination of the Prohibited Substances and Prohibited Methods that will be included on the Prohibited List and which shall apply to the relevant Match shall be final and shall not be subject to challenge by a Cricketer or any other person based on any reason.

5.3

Therapeutic Use Exemptions

5.3.1

The presence of a Prohibited Substance or its Metabolites or Marker (Clause 3.1), Use or Attempted Use of a Prohibited Substance or Prohibited Method (Clause 3.2), Possession of Prohibited Substances and Prohibited Methods (Clause 3.5) or Administration or Attempted Administration of a Prohibited Substance or Prohibited Method (Clause 3.7) consistent with the provision of an applicable and current Therapeutic Use Exemption shall not be considered an Anti-Doping Code Violation.

5.3.2

A Cricket Player with a documented medical condition, the treatment of which requires the Use of a Prohibited Substance or a Prohibited Method, may apply to the Medical Committee for approval to Use the Prohibited Substance or Prohibited Method in accordance with the International Standard for Therapeutic Use Exemptions and this Anti-Doping Code.

5.3.3

CLT20 shall appoint a Medical Committee to consider requests for Therapeutic Use Exemptions. Upon CLT20's receipt of a Therapeutic Use Exemption request, the Chair of the Medical Committee shall appoint one or more members of the Medical Committee (which may include the Chair) to consider such request. The Medical Committee member(s) so designated shall promptly evaluate such request in accordance with the International Standard for Therapeutic Use Exemptions and render a decision on such request, which shall be the final decision of CLT20. Therapeutic Use Exemptions may be granted on such terms and conditions as the Medical Committee member(s) deem appropriate in their absolute discretion. If a Cricket Player does play after receipt of a Therapeutic Use Exemption, the act of playing is deemed to be his acceptance and agreement to the conditions, if any, attaching to the Therapeutic Use Exemption.

5.3.4

In considering any such application, the Medical Committee will have regard to the following:

5.3.4.1	Whether the Cricket Player has a significant medical condition which requires treatment;
5.3.4.2	Whether an unfair advantage will result from the administration of the Prohibited Substance or Prohibited Method as medically prescribed; and
5.3.4.3	Whether there is an alternative medication which is not prohibited which can be safely substituted for the Prohibited Substance or Prohibited Method.

5.3.5	Where a significant medical condition requiring medical treatment arises during a Match the Cricket Player shall be required to submit an emergency Therapeutic Use Exemption application to the Medical Committee. Such applications will be considered in accordance with the provisions of clause 5.3.4 on an expedited basis.
5.3.6	Where a Cricket Player needs emergency medical treatment and there is not sufficient time to submit an emergency Therapeutic Use Exemption application beforehand due to urgent medical necessity then a Therapeutic Use Exemption may be granted retrospectively. The application shall be submitted to the Medical Committee as soon as possible after the administration of the medical treatment and will be considered, in accordance with the provisions of clause 5.3.4, on an expedited basis.
5.3.7	Save for applications submitted and granted under clause 5.3.6 above, a Therapeutic Use Exemption cannot be granted retrospectively.
5.3.8	A valid Therapeutic Use Exemption which has been granted by a Cricket Player's Home Board, or other WADA compliant organisation prior to the commencement of the Season shall be automatically valid as a Therapeutic Use Exemption for the purposes of this Anti-Doping Code provided that the Cricket Player seeking to rely on such grant can produce clear documentary evidence to prove an application was made to and granted by the relevant Home Board and that such exemption is still valid at the time of the relevant Match.
5.3.9	Therapeutic Use Exemptions granted by the Medical Committee shall be reported to CLT20 who shall in turn report to WADA.
5.3.10	WADA, at the request of a Cricket Player or on its own initiation, may review the granting or denial of any Therapeutic Use Exemption to a Cricket Player. If WADA determines that the granting or denial of a Therapeutic Use Exemption did not comply with the International Standard for Therapeutic Use Exemptions in force at the time then WADA may reverse that decision. If WADA reviews a decision to grant or deny a Therapeutic Use Exemption it shall notify the relevant Cricket Player and CLT20 and shall keep them informed of the progress of the review. Decisions on Medical Exemptions/ Therapeutic Use Exemptions are subject to further appeal as provided in Clause 15.4.

6 Testing

6.1

Authority to Test

All Cricket Players participating in Matches are subject to In-Competition and Out-of-Competition testing by CLT20, who shall appoint the relevant Anti-Doping Organisation to be responsible for Testing at the relevant Match. Cricket Players agree to submit to all In-Competition and Out-of-Competition Testing (at any reasonable place, with or without advance notice) by CLT20's appointed Anti-Doping Organisation. This includes at training, at team hotels or at any other suitable facility. Cricket Players are liable to be selected for any number of drug tests; there is no maximum number. Target Testing is completely acceptable.

6.2

Responsibility for Testing

CLT20 shall be responsible for overseeing any Testing conducted by the appointed Anti-Doping Organisation.

6.3

Testing Standards

All Testing conducted by CLT20 at Matches shall be in conformity with the International Standard for Testing in force at the time of that Testing.

6.4

Selection of Cricketers to be Tested

6.4.1	CLT20 shall determine the number of Cricket Players to be tested during the relevant Season (which includes the Support Period).
6.4.2	Selection of Cricket Players for testing in accordance with clause 6.4.1 will be conducted in accordance with Schedule 3.

6.5

Retirement

Should a Cricket Player retire during a Match or the Season, such retirement shall not:

6.5.1	excuse the Cricket Player from providing a Sample, provided such Sample was requested prior to the Cricket Player's retirement;
6.5.2	prevent the analysis of such Sample provided by the Cricket Player prior to the Cricket Player's retirement;
6.5.3	affect the results of any testing in respect of such Sample;
6.5.4	affect the imposition of any sanction pursuant to this Anti-Doping Code; or
6.5.5	excuse the Cricket Player from assisting, cooperating and liaising with CLT20 and any Anti-Doping Organisation in relation to the conduct of any investigation or hearing into an alleged Anti-Doping Code Violation.
	A Cricket Player may make a written request to CLT20 for reinstatement after his retirement. The request is taken to be made on the date CLT20 receves the request. Reinstatement will be at the discretion of CLT20. This Anti-Doping Code will apply to the Cricket Player from the date of the reinstatement request.

6.6

Subject to the terms of this Anti-Doping Code (including Schedule 3), the collection, storage and transport of Samples shall be carried out in accordance with International Standards.

7 Analysis Of Samples

Samples collected under this Anti-Doping Code shall be analysed to detect Prohibited Substances and Prohibited Methods in accordance with the principles set out in this Clause 7. Samples shall be analysed to detect Prohibited Substances and Prohibited Methods identified on the Prohibited List.

7.1	Use of Approved Laboratories
	CLT20 shall send Samples for analysis only to WADA-Accredited Laboratories or as otherwise approved by WADA. The choice of the WADA-Accredited Laboratory (or other method approved by WADA) used for the Sample analysis shall be determined exclusively by CLT20.
7.2	Standards for Sample Analysis and Reporting
	Laboratories must analyse Samples and report results in conformity with all applicable International Standards.
7.3	Research on Samples
	No Sample may be used for any purpose other than the detection of substances (or classes of substances) or methods on the Prohibited List, or as otherwise identified by WADA pursuant to its Monitoring Program, without the Cricket Player's written consent. Samples used for any other purposes shall have any means of identification removed such that they cannot be traced back to a particular Cricket Player.
7.4	Minor Irregularities
	Minor irregularities in testing, which cannot reasonably be considered to have affected the results of otherwise valid tests, will have no effect on such results.

8 Results Management

8.1

Initial Review Regarding Adverse Analytical Findings

Results management for Adverse Analytical Findings arising from Testing shall proceed as set forth below:

8.1.1	The results from all analyses must be sent to CLT20 (who shall send it to the Medical Committee) in encoded form, in a report signed by an authorised representative of the laboratory. All communication must be conducted in such a way that the results of the analyses are confidential.
8.1.2	Upon receipt of an A Sample Adverse Analytical Finding, in respect of a Cricket Player the Medical Committee shall conduct a review to determine whether: (a) an applicable Therapeutic Use Exemption has been granted to that Cricket Player, or (b) there is any apparent departure from any International Standards that undermines the validity of the Adverse Analytical Finding.
8.1.3	If the initial review under Clause 8.1.2 does not reveal an applicable Therapeutic Use Exemption or departure from any International Standard in force at the time of testing or analysis that undermines the validity of the Adverse Analytical Finding, CLT20 shall promptly notify the Cricket Player, his Team and Home Board of: (a) the Adverse Analytical Finding; (b) the alleged Anti-Doping Code Violation, or, in a case under Clauses 8.3.1 or 8.3.2, a description of the additional investigation that will be conducted as to whether the alleged Anti-Doping Code Violation is proven; (c) the Cricket Player's right to promptly request the analysis of the B Sample or, failing such request, that the B Sample analysis may be deemed waived; (d) the scheduled date, time and place for the B Sample analysis if the Cricket Player or CLT20 chooses to request an analysis of the B Sample; (e) the right of the Cricket Player's and/or the Cricket Player's representative to attend the B Sample opening and analysis if such analysis is requested; and (f) the Cricket Player's right to request copies of the A Sample and B Sample laboratory documentation package which includes information as required by the International Standard for Laboratories.
8.1.4	Where requested, arrangements shall be made for testing the B Sample on an expedited basis. A Cricket Player may accept the A Sample analytical results by waiving the requirement for B Sample analysis. CLT20 may nonetheless elect to proceed with the B Sample analysis.
8.1.5	The Cricket Player and/or his representative shall be allowed to be present at the analysis of the B Sample. A representative of CLT20 shall also be allowed to be present.
8.1.6	If the B Sample proves negative, the entire test shall be considered negative and the Cricket Player, his Team and Home Board and CLT20 shall be so informed.
8.1.7	For the avoidance of doubt, the costs for testing both A Sample and B Sample shall be borne by CLT20.
8.1.8	If a Prohibited Substance, its Metabolites or Markers or the Use of a Prohibited Method is identified in the B Sample analysis, the findings shall be reported to the Cricket Player, his Team, CLT20, his Home Board and to WADA.

8.2

Review of Atypical Findings

8.2.1

WADA-Accredited Laboratories are directed to report the presence of Prohibited Substances, which may also be produced endogenously, as Atypical Findings subject to further investigation. Upon receipt of an A Sample Atypical Finding for a Cricket Player, the Medical Committee shall conduct a review to determine whether: (a) an applicable Therapeutic Use Exemption has been granted to that Cricket Player, or (b) there is any apparent departure from the International Standard for Testing or International Standard for Laboratories that caused the Atypical Finding.

8.2.2

If the initial review under Clause 8.2.1 does not reveal an applicable Therapeutic Use Exemption or departure from any International Standard in force at the time of testing or analysis that undermines the validity of the Atypical Finding, CLT20 shall conduct further investigation pursuant to Clause 8.3.

8.3

Further Investigations

8.3.1	1 The Medical Committee shall conduct any follow-up investigation as may be required in respect of an Adverse Analytical Finding and/or an Atypical Finding. Upon completion of such follow-up investigation, CLT20 shall promptly notify the Cricketer regarding the results of the follow-up investigation and whether or not CLT20 alleges that an Anti-Doping Code Violation has occurred.
8.3.2	For apparent Anti-Doping Code Violations that do not involve Adverse Analytical Findings, CLT20 shall conduct any necessary follow-up investigation and shall then promptly notify the Cricketer whether or not CLT20 alleges that an Anti-Doping Code Violation has occurred, and the basis of any alleged violation.

8.4

Results Management

Where a Cricketer admits to a Doping practice or CLT20 reasonably believes that a Cricketer may have committed an Anti-Doping Code Violation, CLT20 must do all of the following:

8.4.1

refer the matter to the Drugs Tribunal for a hearing; and

8.4.2

immediately suspend the Cricketer from participating in any Match and the Team shall take all such steps to ensure that such Provisional Suspension occurs (including its organisation, administration and promotion) until after any final decision (inclusive of any appeal) relating to the Cricketer's alleged Doping practice or Anti-Doping Code Violation has been made provided, however, that a Provisional Suspension may not be imposed unless the Cricketer is given either:

(a)	an opportunity for a provisional hearing either before imposition of the Provisional Suspension or on a timely basis after imposition of the Provisional Suspension; or
(b)	an opportunity for an expedited hearing in accordance with Clause 14 on a timely basis after imposition of the Provisional Suspension; and

8.4.3	notify the Cricketer in writing that CLT20 has referred the matter to the Drugs Tribunal for a hearing to be conducted to enquire and determine whether an Anti-Doping Code Violation has been committed and whether a sanction will be imposed under this Anti-Doping Code and that the Cricketer has been provisionally suspended pursuant to clause 8.4.2. Such notification shall also enclose a copy of all reports, analyses and any other documentation received by CLT20 from the relevant Anti-Doping Organisation and laboratory in relation to the Cricketer; and
8.4.4	invite the Cricketer and the Cricketer's legal representative (if any) and a representative of the Cricketer's Team to attend the hearing referred to in such notice, to present relevant material and submissions, and to be heard by the Drugs Tribunal as to why the Cricketer should not be found guilty and subject to the sanctions prescribed in this Anti-Doping Code; and
8.4.5	Subject to Clause 16.2, issue a media release containing any reasonable details in this regard that CLT20 shall, in its discretion, determine appropriate.

9 Sanctions On Individuals

9.1

Disqualification of Results in a Match during which an Anti-Doping Code Violation Occurs

9.1.1

A proven Anti-Doping Code Violation by a Cricketer occurring during or in connection with a Match may lead to forfeiture of his share in any Team prizes and disqualification of his performance statistics in individual records in connection with the League except as provided in Clause 9.1.2. (For the avoidance of doubt the relevant Team score of the Match in connection with which the Anti-Doping Code Violation was established shall not be altered at all.)

9.1.2

If the Cricketer establishes that he bears No Fault or Negligence for the violation, the Cricketer's individual results in the Match shall not be disqualified unless the Cricketer's results in the Match in which the Anti-Doping Code Violation occurred were likely to have been materially affected by the Cricketer's Anti-Doping Code Violation.

9.2	Imposition of Ineligibility for Presence, Use or Attempted Use, or Possession of Prohibited Substances and Prohibited Methods
	Except for the Specified Substances identified in Clause 9.3, the period of Ineligibility imposed for a violation of Clause 3.1 (presence of Prohibited Substance or its Metabolites or Markers), Clause 3.2 (Use or Attempted Use of Prohibited Substance or Prohibited Method) and Clause 3.5 (Possession of Prohibited Substances and Methods) shall be as follows, unless the conditions for eliminating or reducing the period of Ineligibility, as provided in Clause 9.5, or the conditions for increasing the period of Ineligibility, as provided in Clause 9.6, are met::
	First violation: Two (2) years' Ineligibility
9.3	Elimination or Reduction of the Period of Ineligibility for Specified Substances under Specific Circumstances
	The Prohibited List may identify Specified Substances which are particularly susceptible to unintentional Anti-Doping Code Violations because of their general availability in medicinal products or which are less likely to be successfully abused as Doping agents. Where a Cricket Player or other person can establish how a Specified Substance entered the Cricket Player's body or came into their Possession and that such Specified Substance had No Performance Enhancing Effect, the period of Ineligibility found in Clause 9.2 shall be replaced with the following (subject also to Clause 9.5):
	First violation: At a minimum, a reprimand and no period of Ineligibility from future Matches, and at a maximum, two (2) year's Ineligibility.
	To justify any elimination or reduction, the Cricket Player or other person must produce corroborating evidence in addition to his or her word which establishes on the balance of probabilities to the Drugs Tribunal or Drugs Appeals Tribunal, as the case may be, No Performance Enhancing Effect. The Cricket Player's or other person's degree of fault shall be the criterion considered in assessing any reduction of the period of Ineligibility.

9.4

Ineligibility for Other Anti Doping Code Violations

Subject to Clause 9.5, the period of Ineligibility for other Anti-Doping Code Violations other than as provided in Clause 9.2 shall be as follows:

9.4.1

For violations of Clause 3.3 (refusing or failing to submit to Sample collection) or Clause 3.4 (Tampering with Doping Control), the Ineligibility period shall be two (2) years.

9.4.2

For violations of Clause 3.6 (Trafficking) or Clause 3.7 (administration or Attempted administration of Prohibited Substance or Prohibited Method), the period of Ineligibility imposed shall be a minimum of four (4) years up to lifetime Ineligibility. An Anti-Doping Code Violation involving a minor shall be considered a particularly serious violation and, if committed by Cricket Support Personnel for violations other than Specified Substances referenced in Clause 9.3, shall result in lifetime Ineligibility for such Cricket Support Personnel. In addition, violations of such Clauses which also violate non-sporting laws and regulations, shall be reported to the competent administrative, professional or judicial authorities.

9.5

Elimination or Reduction of Period of Ineligibility Based on Exceptional Circumstances of

9.5.1	No Fault or Negligence
	If a Cricket Player or other person establishes in an individual case involving an Anti-Doping Code Violation that he bears No Fault or Negligence, he shall be found to have committed no Anti-Doping Code Violation and the otherwise applicable period of Ineligibility shall be eliminated. When a Prohibited Substance or its Markers or Metabolites is detected in a Cricket Player's Sample in violation of Clause 3.1 (presence of Prohibited Substance), the Cricket Player must also establish how the Prohibited Substance entered his system in order that no violation be found to have been committed and to have the period of Ineligibility eliminated. For the purpose of determining the period of Ineligibility for multiple violations under Clause 9.7, a "no violation" finding shall be recorded.
9.5.2	No Significant Fault or Negligence
	If a Cricket Player or other person establishes in an individual case involving an Anti-Doping Code Violation that he bears No Significant Fault or Negligence, then the otherwise applicable period of Ineligibility may be reduced, but the reduced period of Ineligibility under this Clause may not be less than one-half of the period of Ineligibility otherwise applicable. If the otherwise applicable period of Ineligibility is a lifetime, the reduced period under this section may be no less than 8 years.
	When a Prohibited Substance or its Markers or Metabolites is detected in a Cricket Player's Sample in violation of Clause 3.1 (presence of Prohibited Substance), the Cricket Player must also establish how the Prohibited Substance entered his system in order to have the period of Ineligibility reduced.
9.5.3	Substantial Assistance in Discovering or Establishing Anti-Doping Code Violations
	The Drugs Tribunal/Drugs Appeal Tribunal may, prior to a final appellate decision under Clause 13 or the expiration of time to appeal, also suspend part of the period of Ineligibility imposed in an individual case where a Cricketer has provided Substantial Assistance to CLT20, an Anti-Doping Organisation, a judicial authority or a professional disciplinary body which results in CLT20, an Anti-Doping Organisation, a judicial authority or a professional disciplinary body discovering or establishing an Anti-Doping Code Violation by another person or which results in a judicial authority or disciplinary body discovery or establishing a criminal offence or breach of professional rules by another person. After a final appellate decision under Clause 13 or the expiration of time to appeal, CLT20 (or the Drugs Tribunal, as the case may be) or any Anti-Doping Organisation may only suspend a part of the otherwise applicable period of Ineligibility with the approval of WADA.
	The extent to which the otherwise applicable period of Ineligibility may be suspended shall be based on the seriousness of the Anti-Doping Code Violation committed by the Cricketer and the significance of the Substantial Assistance provided by the Cricketer to the effort to eliminate Doping in sport. No more than three-quarters of the otherwise applicable period of Ineligibility may be suspended. If the otherwise applicable period of Ineligibility is a lifetime, the non-suspended period under this Clause must be no less than 8 years. If CLT20 subsequently reinstates any part of the suspended period of Ineligibility because the Cricketer has failed to provide the Substantial Assistance which was anticipated, the Cricketer may appeal the reinstatement pursuant to Clause 13.
9.5.4	Admission of an Anti-Doping Code Violation in the Absence of Other Evidence
	Where a Cricketer voluntarily admits the commission of an Anti-Doping Code Violation before having received notice of a Sample collection which could establish an Anti-Doping Code Violation (or, in the case of an Anti-Doping Code Violation other than Clause 3.1, before receiving first notice of the admitted violation pursuant to Clause 8.4) and that admission is the only reliable evidence of the violation at the time of admission, then the period of Ineligibility may be reduced, but not below one-half of the period of Ineligibility otherwise applicable.
9.5.5	Where a Cricketer Establishes Entitlement to Reduction in Sanction Under More than One Provision of this Clause 9.5.
	Before applying any reduction or suspension under Clauses 9.5.2, 9.5.3 or 9.5.4, the otherwise applicable period of Ineligibility shall be determined in accordance with Clauses 9.2, 9.3, and 9.4. If the Cricketer establishes entitlement to a reduction or suspension of the period of Ineligibility under two or more of Clauses 9.5.2, 9.5.3 or 9.5.4, then the period of Ineligibility may be reduced or suspended, but not below one-quarter of the otherwise applicable period of Ineligibility.

9.6	Aggravating Circumstances Which May Increase the Period of Ineligibility.
	If CLT20 (or the Drugs Tribunal as the case may be) establishes in an individual case involving an Anti-Doping Code Violation other than violations under Clauses 3.6 (Trafficking or Attempted Trafficking) and 3.7 (Administration or Attempted Administration) that aggravating circumstances are present that justify the imposition of a period of Ineligibility greater than the standard sanction, then the period of Ineligibility otherwise applicable shall be increased up to a maximum of four (4) years unless the Cricketer can prove on the balance of probabilities to the Drugs Tribunal or Drugs Appeal Tribunal, as the case may be, that he did not knowingly commit the Anti-Doping Code Violation.
	A Cricketer can avoid the application of this Clause by admitting the Anti-Doping Code Violation as asserted promptly after being confronted with the Anti-Doping Code Violation by an Anti-Doping Organisation.

9.7

Multiple Violations

9.7.1

Second Anti-Doping Code Violation

Second Violation

First Violation

	RS	NSF	St	AS	TRA
RS	1-4	2-4	4-6	8-10	10-life
NSF	1-4	4-8	6-8	10-life	life
St	2-4	6-8	8-life	life	life
As	4-5	10-life	life	life	life
TRA	8-life	life	life	life	life

The table is applied by locating the Cricket Player's or other person's first Anti-Doping Code Violation in the left-hand column and then moving across the table to the right to the column representing the second Anti-Doping Code Violation. The Cricket Player's or other person's degree of fault shall be the criterion considered in assessing a period of Ineligibility within the applicable range.

Definitions for the purposes of the second Anti-Doping Code Violation table are as follows:

RS (Reduced sanction for Specified Substance under Clause 9.3): The Anti-Doping Code Violation was or should be sanctioned by a reduced sanction under Clause 9.5 because it involved a Specified Substance and the other conditions under Clause 9.5 were met.

NSF (Reduced sanction for No Significant Fault or Negligence): The Anti-Doping Code Violation was or should be sanctioned by a reduced sanction under Clause 9.5.2 because No Significant Fault or Negligence under Clause 9.5.2 was proved by the Cricketer.

St (Standard sanction under Clause 9.2 or 9.4.1): The Anti-Doping Code Violation was or should be sanctioned by the standard sanction of two years under Clause 9.2 or 9.4.1.

AS (Aggravated sanction): The Anti-Doping Code Violation was or should be sanctioned by an aggravated sanction under Clause 9.6 because CLT20 (or the Drugs Tribunal, as the case may be) established the conditions set forth under Clause 9.6.

TRA (Trafficking or Attempted Trafficking and Administration or Attempted Administration): The Anti-Doping Code Violation was or should be sanctioned by a sanction under Clause 9.4.2.

9.7.2	Application of Clauses 9.5.3 and 9.5.4 to Second Anti-Doping Code Violation.
	Where a Cricketer who commits a second Anti-Doping Code Violation establishes entitlement to suspension or reduction of a portion of the period of Ineligibility under Clauses 9.5.3 or 9.5.4, the Drugs Tribunal or Drugs Appeals Tribunal, as the case may be, shall first determine the otherwise applicable period of Ineligibility within the range established in the table in Clause 9.7.1, and then apply the appropriate suspension or reduction of the period of Ineligibility. The remaining period of Ineligibility, after applying any suspension or reduction under Clauses 9.5.3 and 9.5.4, must be at least one-quarter of the otherwise applicable period of Ineligibility.
9.7.3	Third Anti-Doping Code Violation
	A third Anti-Doping Code Violation will always result in a lifetime period of Ineligibility, except if the third violation fulfills the condition for elimination or reduction of the period of Ineligibility under Clause 9.3. In these particular cases, the period of Ineligibility shall be from eight years to a life ban.

9.8

Additional Rules for Certain Potential Multiple Violations

9.8.1	For purposes of imposing sanctions under Clause 9.7, a second or subsequent Anti-Doping Code Violation will only be considered a further violation if CLT20 can establish that the Cricketer committed the second or subsequent Anti-Doping Code Violation after the Cricketer received notice, or after CLT20 made a reasonable attempt to give notice, of the prior Anti-Doping Code Violation; if CLT20 cannot establish this, the violations shall be considered together as one single violation, and the sanction imposed shall be based on the violation that carries the more severe sanction; however, the occurrence of multiple violations may be considered as a factor in determining aggravating circumstances under Clause 9.6.
9.8.2	If, after the resolution of a first Anti-Doping Code Violation, CLT20 discovers facts involving an Anti-Doping Code Violation by a Cricketer which occurred prior to notification regarding the first Anti-Doping Code Violation, then CLT20 shall impose an additional sanction based on the sanction that could have been imposed if the two Anti-Doping Code Violations would have been adjudicated at the same time. Individual results in all Matches dating back to the earlier Anti-Doping Code Violation will, unless fairness requires otherwise, be disqualified with the resulting consequences including forfeiture of any records and prizemoney. To avoid the possibility of a finding of aggravating circumstances (Clause 9.6) on account of the earlier-in-time but later-discovered Anti-Doping Code Violation, the Cricketer must voluntarily admit the earlier Anti-Doping Code Violation on a timely basis after notice of the Anti-Doping Code Violation for which he is first charged. The same rule shall also apply when CLT20 discovers facts involving another prior Anti-Doping Code Violation after the resolution of a second Anti-Doping Code Violation.
9.8.3	Where a Cricketer, based on the same Doping Control, is found to have committed an Anti-Doping Code Violation involving both a Specified Substance under Clause 9.3 and another Prohibited Substance or Prohibited Method, the Cricketer shall be considered to have committed a single Anti-Doping Code Violation, but the sanction imposed shall be based on the Prohibited Substance or Prohibited Method that carries the most severe sanction.

9.9	Multiple Anti-Doping Code Violations during Eight Year Period
	For the purposes of this Clause 9, each Anti-Doping Code Violation must take place within the same eight year period in order to be considered multiple violations.
9.10	Commencement of Ineligibility Period
	The period of Ineligibility shall start on the date of the hearing decision providing for Ineligibility or, if the hearing is waived, on the date Ineligibility is accepted or otherwise imposed. Any period of Provisional Suspension (whether imposed or voluntarily accepted under Clause 8.4.2) shall be credited against the total period of Ineligibility to be served. Where required by fairness, such as delays in the hearing process or other aspects of Doping Control not attributable to the Cricketer, CLT20 or the relevant Anti-Doping Organisation imposing the sanction may start the period of Ineligibility at an earlier date commencing as early as the date of Sample collection.
9.11	Status During Provisional Suspension
	The Cricketer shall be prevented from participating in any Match (including its organisation, administration and promotion) until after any final decision (inclusive of any appeal) relating to the Cricketer's alleged Anti-Doping Code Violation has been made. Where the Cricketer has ingested a Prohibited Substance he shall remain provisionally suspended until he has successfully completed reinstatement testing in accordance with Clause 9.14 and this shall apply regardless of the outcome of the final decision (inclusive of any appeal). For avoidance of doubt this Clause 9.11 shall apply even if the Cricketer establishes No Fault or Negligence.
9.12	Prohibition on Participation During Ineligibility
	No Cricketer who has been declared Ineligible may, during the period of Ineligibility, participate in any capacity in any Match during the Ineligibility period. This would preclude, but not be limited to: 1. attending any practice or training session with any Team or any member of a Team in connection with the League; 2. acting as a coach of any Team or as an official of any Team or an official in connection with the League; 3. receiving payment from CLT20 or his Team in respect of his personal services; 4. using facilities or equipment owned or controlled by CLT20; and/or 5. holding any official position with CLT20. In addition, for any Anti-Doping Code Violation not involving Specified Substances described in Clause 3.1 some or all sport-related financial support or other sport-related benefits received by such Cricketer will be withheld by CLT20.
9.13	Violation of Prohibition on Participation during Ineligibility
	Where a Cricketer who has been declared Ineligible violates the prohibition against participation during Ineligibility set out in Clause 9.12, the period of Ineligibility which was originally imposed shall start over again as of the date of the violation, unless the Cricketer or other person can establish to the Drugs Tribunal or Drugs Appeal Tribunal, as the case may be, that he bears No Fault or Negligence. The new period of Ineligibility may be reduced if the Cricketer or other person establishes he bears No Significant Fault or Negligence for violating the prohibition against participation. The determination of whether a Cricketer has violated the prohibition against participation, whether the Cricketer has established No Fault or Negligence and whether a reduction under Clause 9.5.2 is appropriate, shall be made by the Drugs Tribunal, and such determinations may be appealed as provided in Clause 13.
9.14	Reinstatement Testing As a condition to regaining eligibility at the end of a specified period of Ineligibility, a Cricket Player must, during any period of Provisional Suspension or Ineligibility, make himself available for testing by CLT20 and any other Anti-Doping Organisation having Testing jurisdiction over such Cricket Player.

10 Consequences To Teams

10.1

Where more than one Team member from the same Team has been notified of a possible Anti-Doping Code Violation under Clause 8 in connection with a Match, the Team shall be subject to Target Testing for the relevant Season.

10.2

Save for those alleged Anti-Doping Code Violations where the Cricketer or other person establishes No Fault or Negligence, No Significant Fault or Negligence, or No Significant Fault or Negligence and No Performance Enhancing Effect during the relevant Match, if more than two Team members from the same Team are found to have committed an Anti-Doping Code Violation during a Season, the Team may be subject to disqualification or other disciplinary action at the discretion of CLT20, in addition to any sanctions imposed on the individual Cricketers committing the Anti-Doping Code Violations.

11 Sanctions And Costs Assessed Against Teams

11.1	Circulation of information to players.
	Every Team participating in a Match is required to ensure, and is responsible for ensuring (in addition to any obligation or responsibility on any Cricketer), that Cricketers contracted to such Team are aware of and have access to this Anti-Doping Code.
11.2	Penalty for breach by Team
	Any Team that has been determined, in the reasonable opinion of CLT20, to have failed to use best endeavours to circulate information to players in terms of clause 11.1 of this Anti-Doping Code shall be liable to a fine not exceeding US$ 50,000.

12 Drugs Tribunal

12.1	Constitution of the Drugs Tribunal
	The CLT20 will, at the time of any alleged Anti-Doping Code Violations, establish a specific Drugs Tribunal to deal with such allegations. Such Drugs Tribunal shall consist of three members, namely:-

12.1.1	A senior legal practitioner who will act as chairperson of the Drugs Tribunal;
12.1.2	An eminent medical practitioner with knowledge of Doping practices in sport; and
12.1.3	An eminent former Cricketer.
	The Drugs Tribunal has the power to hear and determine all matters arising from any matter that is referred to it by CLT20 pursuant to clause 8.2.1 of this Anti-Doping Code. In particular, it has the power to impose the sanctions provided for in clause 9.

12.3	Procedures of the Drugs Tribunal
	The Drugs Tribunal will observe the procedures set out in Schedule 1 to this Anti-Doping Code.
12.4	Proceedings not to be invalidated for technical reasons
	No proceedings heard by the Drugs Tribunal shall be quashed or held invalid by reason only of any reasonable defect, irregularity, omission or other technicality provided there has been no miscarriage of the principles of natural justice as contained in the CLT20 Operational Rules in force at the time of the relevant Match.
12.5	Autonomy of the Drugs Tribunal
	The Drugs Tribunal constituted under this Anti-Doping Code shall exercise its functions independently of CLT20. The Drugs Tribunal shall be fully autonomous and in particular any decision it makes shall be binding on CLT20, which shall not have the power to affirm, revoke or alter any decision.

13 Drugs Appeal Tribunal

13.1	Constitution of the Drugs Appeal Tribunal
	CLT20 will, as soon as is necessary, establish a body known as the Drugs Appeal Tribunal for the League. The Drugs Appeal Tribunal will consist of three members, namely:-

13.1.1	A senior legal practitioner who will act as chairperson of the Drugs Appeal Tribunal;
13.1.2	An eminent medical practitioner with knowledge of Doping practices in sport; and
13.1.3	An eminent former Cricketer.

13.2	General jurisdiction of the Drugs Appeal Tribunal
	The Drugs Appeal Tribunal shall have the power to hear and determine appeals from any decision of the Drugs Tribunal.
13.3	Appeals may be conducted by way of rehearing
	When any question of fact arises on an appeal before the Drugs Appeal Tribunal, it shall be determined by reference to the record of proceedings before the Drugs Tribunal provided that the Drugs Appeal Tribunal in its discretion may rehear the whole or any part of the evidence given before the Drugs Tribunal as it considers appropriate.
13.4	Sanction stayed
	Any sanction imposed by the Drugs Tribunal will be stayed pending the decision of the Drugs Appeal Tribunal. Any Provisional Suspension in force pursuant to clause 8.4.2 is not affected by this clause 13.4.
13.5	Further evidence
	The Drugs Appeal Tribunal shall have full discretionary power to hear and receive such further evidence on appeal as it thinks fit provided it is established that such evidence was not, on reasonable enquiry, available at the time of the original hearing. The Drugs Appeal Tribunal shall be entitled to receive such evidence as it thinks fit notwithstanding that the evidence may not be legally admissible in a court of competent jurisdiction.
13.6	Powers on appeal
	In exercising its jurisdiction, the Drugs Appeal Tribunal shall have the power to impose a penalty, or to quash, suspend, vary, increase or decrease the penalty appealed against, subject to the mandatory nature of any sanctions provided for in clause 9.
13.7	Procedures of the Drugs Appeal Tribunal
	The Drugs Appeal Tribunal shall observe the procedures set out in Schedule 2 of this Anti-Doping Code.
13.8	Proceedings not to be invalidated for technical reasons
	No proceedings heard by the Drugs Appeal Tribunal shall be quashed or held invalid by reason only of any reasonable defect, irregularity, omission or other technicality provided there has been no miscarriage of the principles of natural justice as contained in the CLT20 Operational Rules in force at the time of the relevant Match.
13.9	Costs
	The Drugs Appeal Tribunal may make an award of costs in respect of costs incurred by the Cricketer, CLT20 and/or the Drugs Appeal Tribunal if it finds the appeal before it to be Spurious or Frivolous.
13.10	Autonomy of the Drugs Appeal Tribunal

13.10.1	The Drugs Appeal Tribunal constituted under this Anti-Doping Code shall exercise its functions independently of CLT20.
13.10.2	The Drugs Appeal Tribunal shall be fully autonomous and in particular any decision it makes shall be binding on CLT20, which shall not have the power to affirm, revoke or alter any decision.

13.11	No Cricketer or any other person subject to this Anti-Doping Code shall be entitled to pursue any recourse in respect of a doping matter, in a court of law unless such party has exhausted all the provisions of this Anti-Doping Code.
13.12	Subject to clause 15, decisions of the Drugs Appeal Tribunal are final.
13.13	Who May Appeal
	The Cricketer or CLT20 may appeal to the Drugs Appeal Tribunal against a decision of the Drugs Tribunal. The provisions of Schedule 2 of this Anti-Doping Code will apply to an appeal lodged by CLT20 mutatis mutandis (other than in relation to matters of an administrative nature which will continue to be performed by CLT20).

14 Right to a Fair Hearing

14.1	Hearings conducted under this Anti Doping Code shall respect the following principles:
	o a timely hearing;
	o fair and impartial hearing body;
	o the right to be represented by counsel at the Cricketer's own expense;
	o the right to be informed in a fair and timely manner of the asserted Anti Doping Code Violation;
	o the right to respond to the asserted Anti-Doping Code Violation and resulting consequences;
	o the right of each party to present evidence, including the right to call and question witnesses (subject to the hearing body's discretion to accept testimony by telephone or written submission);
	o the Cricketer's right to an interpreter at the hearing, with the Drugs Tribunal and/or Drugs Appeal Tribunal to determine the identity, and responsibility for the cost of the interpreter; and
	o a timely, written, reasoned decision, specifically including an explanation of the reason(s) for any period of Ineligibility.

14.2

CLT20 may decide not to refer the matter to a hearing by the Drugs Tribunal if the Cricketer in writing:

(I)

acknowledges that he has committed an Anti-Doping Code Violation; and

(II)

waives the right to a hearing in relation to:

a	whether the Cricketer committed an Anti-Doping Code Violation; and
b	what sanction will apply.

	CLT20 may then apply a sanction as set out in Clause 9.
14.3	Any case before the Court of Arbitration for Sport shall be handled in accordance with the Court of Arbitration for Sport appeal procedure.

15 Court Of Arbitration for Sport Appeals

15.1	Decisions Subject to Appeal
	Decisions made under this Anti-Doping Code may be appealed to CAS as set forth below in Clause 15.2 through 15.4. Such decisions shall remain in effect while under appeal unless the appellate body orders otherwise. Before an appeal is commenced, all hearings authorised in Clauses 12 and 13 must be exhausted.
15.2	Appeals from Decisions Regarding Anti-Doping Code Violations, Consequences, and Provisional Suspensions
	A decision that an Anti-Doping Code Violation was committed, a decision imposing consequences for an Anti-Doping Code Violation, a decision that no Anti-Doping Code Violation was committed; a decision that an Anti-Doping Code Violation proceeding cannot go forward for procedural reasons (including, for example, prescription); a decision under Clause 9.13 (prohibition of participation during Ineligibility); a decision that CLT20 lacks jurisdiction to rule on an alleged Anti-Doping Code Violation or its consequences, a decision by an Anti-Doping Organisation not to bring forward an Adverse Analytical Finding or an Atypical Finding as an Anti-Doping Code Violation, or a decision not to go forward with an Anti-Doping Code Violation after an investigation under Clause 8.3; a decision to deny or grant Therapeutic Use Exemptions; and a decision to impose a Provisional Suspension as a result of a provisional hearing or otherwise in violation of Clause 8.4.2 may be appealed exclusively as provided in this Clause 15.2. In cases under Clause 15.2. the following parties shall have the right to appeal to CAS:

(a)	the Cricketer or other person who is the subject of the decision being appealed;
(b)	the other party to the case in which the decision was rendered;
(c)	CLT20; and
(d)	WADA.
	If there is more than one party seeking to appeal, all appeals must be heard together and the outcome of that appeal binds all parties who had the right to appeal.

15.3	Failure to Render a Timely Decision by an Anti-Doping Organisation
	Where, in a particular case, the Drugs Tribunal or an Anti-Doping Organisation (as the case may be) fails to render a decision with respect to whether an Anti-Doping Code Violation was committed within a reasonable deadline set by WADA, WADA may elect to appeal directly to CAS as if the Drugs Tribunal or the Anti-Doping Organisation had rendered a decision finding no Anti-Doping Code Violation.
15.4	Appeals from Decisions Granting or Denying a Therapeutic Use Exemption
	Decisions by WADA reversing the grant or denial of a Therapeutic Use Exemption may be appealed exclusively to CAS by the Cricketer or CLT20. Decisions to deny Therapeutic Use Exemptions, and which are not reversed by WADA, may be appealed by Cricketers to CAS.
15.5	Appeal from Decisions Pursuant to Clause 11
	Decisions by CLT20 pursuant to Clause 11 may be appealed exclusively to CAS by the relevant Team.
15.6	Time for Filing Appeals
	The time to file an appeal to CAS shall be twenty-one (21) days from the date of receipt of the decision by the appealing party. Notwithstanding the above, the following shall apply in connection with appeals filed by a party entitled to appeal but which was not a party to the proceedings having lead to the decision subject to appeal:

(a)	Within ten (10) days from notice of the decision, such party/ies shall have the right to request from the body having issued the decision a copy of the file on which such body relied;
(b)	If such a request is made within the ten-day period, then the party making such request shall have twenty-one (21) days from receipt of the file to file an appeal to CAS.

16 Incorporation of CLT20 Rules, Reporting and Recognition

16.1	Incorporation of CLT20 Anti Doping Code
	All Teams participating in Matches shall comply with this Anti-Doping Code. All Cricketers contracted to or playing for such Teams participating in Matches shall be bound by this Anti Doping Code.
16.2	Public Disclosure
	Neither CLT20 nor Teams shall publicly identify Cricketers whose Samples have resulted in Adverse Analytical Findings, or who were alleged to have committed other Anti-Doping Code Violations until it has been determined in a hearing in accordance with Clause 8 that an Anti-Doping Code Violation has occurred, or such hearing has been waived, or the assertion of an Anti-Doping Code Violation has not been challenged in a timely way or the Cricketer has been the subject of a Provisional Suspension. Once an Anti-Doping Code Violation has been established, it shall be publicly reported within 20 days. CLT20 has the right to issue a press release regarding any decisions of the Drugs Tribunal and Drugs Appeal Tribunal (including with respect to any Provisional Hearing) and to publish any reasons for such decisions.

17 Recognition of Decisions by Other Organisations

17.1	Mutual recognition
	CLT20 recognises that Host Boards and other Anti-Doping Organisations either have or will shortly adopt WADA-compliant anti-doping regulations.
17.2	Mutual enforcement and assistance
	Accordingly, CLT20 shall recognise and enforce any suspension or other penalty imposed pursuant to the anti-doping regulations of a Cricketer's Home Board as if CLT20 had imposed that suspension or other penalty and CLT20 shall offer every reasonable assistance to such Cricketer's Home Board as it may require for the implementation and enforcement of their WADA-compliant anti-doping regulations from time to time.
17.3	Any Cricketer who has been charged with an Anti-Doping Code Violation or comparable behaviour by any signatory to the WADA Code is prohibited from being involved, whether as player, organiser, administrator or promoter, in any Match pending the final resolution of such charge. Results or other final adjudications of any signatories to the WADA Code which are consistent with the WADA Code and are within the signatory's authority, shall be recognised and respected by CLT20. CLT20 may recognise the same actions of other bodies which have not accepted the WADA Code if the rules of those bodies are otherwise consistent with the WADA Code.

18 Amendment and Interpretation of CLT20 Anti-Doping Code

18.1	This Anti-Doping Code may be modified, updated or generally amended from time to time by CLT20. This Anti-Doping Code will come into force and apply to tests carried out from 1 October 2009.
18.2	Except as provided in Clause 18.5, this Anti-Doping Code shall be interpreted as an independent and autonomous text and not by reference to existing law or statutes.
18.3	The headings used for the various Parts and Clauses of this Anti-Doping Code are for convenience only and shall not be deemed part of the substance of this Anti-Doping Code or to affect in any way the language of the provisions to which they refer.
18.4	The INTRODUCTION and the SCHEDULES shall be considered integral parts of this Anti-Doping Code.
18.5	This Anti-Doping Code has been adopted pursuant to the applicable provisions of the WADA Code and shall be interpreted in a manner that is consistent with applicable provisions of the WADA Code.
18.6	This Anti-Doping Code shall not apply retrospectively to matters pending before the date this Anti-Doping Code came into effect.

19 Miscellaneous

19.1	If any clause or provision of this Anti-Doping Code is held invalid, unenforceable or illegal for any reason, this Anti-Doping Code shall remain otherwise in full force apart from such clause or provision which shall be deemed deleted.
19.2	Material Irregularity
	Any deviation from or other irregularity in compliance with the provisions of this Anti-Doping Code or any applicable term of the WADA Code or in the collection, transport, storage or analysis of any Sample does not invalidate any finding, decision or positive test result unless such deviation or irregularity is so material as to cast substantial doubt on the reliability of the positive test result or on the factual basis for such finding or decision.

Schedule 1

Procedure Of The Drugs Tribunal

1. Power To Regulate Own Procedure

The procedure of the Drugs Tribunal in all such proceedings shall be as the particular Drugs Tribunal shall determine in each case but subject to this power to regulate its own procedure, it shall:-

1.1	generally conform with the procedures stated in this Schedule 1; and
1.2	generally conform to the principles of natural justice as contained in the CLT20 Operational Rules in force at the time of the relevant Match and ensure that any Cricketer required to attend a hearing of the Drugs Tribunal be accorded the opportunity to be heard.

2. Notice To The Cricketer

CLT20 shall within 24 hours of a reference being made to the Drugs Tribunal under clause 8.2.1 of the Anti-Doping Code advise the Cricketer in writing:-

2.1	of the date, place and time of the hearing at which the proceedings against the Cricketer will be heard and of the charge;
2.2	that the Cricketer may request reasonable further particulars to the charge;
2.3	that the Cricketer is entitled to legal representation;
2.4	that the Cricketer may call and cross-examine witnesses;
2.5	that the Cricketer has a right of appeal; and
2.6	that if the Cricketer is unable to appear at the hearing as notified the Cricketer should inform CLT20 as soon as practicable.

3. Representation

A Cricketer who is required to attend a hearing by a Drugs Tribunal shall be entitled to be assisted and/or represented at the hearing by a representative of his choice.

4. Powers Of Adjournment

The Drugs Tribunal shall have power to postpone or adjourn a hearing at which proceedings are to be heard and shall furnish reasons for the postponement or adjournment. Any adjournment must be no longer than is consistent with deciding the case fairly and expeditiously. The Drugs Tribunal shall endeavour to ensure that proceedings are not heard in the absence of the Cricketer, but nothing in this Anti-Doping Code shall otherwise prevent a Drugs Tribunal hearing and determining proceedings in the absence of the Cricketer concerned where the Cricketer elects not to attend the hearing.

5. Notice Of Particulars

The Drugs Tribunal shall ensure that prior to the hearing, the Cricketer has been supplied with and has had sufficient opportunity to consider the information provided to the Cricketer pursuant to clause 8.4.3 of this Anti-Doping Code.

6. Requirement To Supply Full Particulars

In the interests of time and minimising inconvenience, a Cricketer whose hearing is pending can be required by the Drugs Tribunal prior to the hearing to supply it with full particulars of the case that will be presented on the Cricketer's behalf at the hearing.

7. Interpreters

Where in any case the Drugs Tribunal considers it necessary or desirable, it may direct CLT20 to have an interpreter present at a hearing.

8. Conduct Of Hearing

Unless it otherwise directs, the procedure of the Drugs Tribunal at the hearing will be as follows:-

8.1	the Chairman will explain the procedure to be followed;
8.2	particulars of the alleged Anti-Doping Code Violation will be presented;
8.3	the Cricketer will enter a plea of guilty or not guilty to the allegations;
8.4	in the event of a plea of not guilty:

8.4.1	the notice received from the relevant Anti-Doping Organisation and associated documentation will be read and any other evidence in support of the allegations will be presented including oral evidence from witnesses; and
8.4.2	evidence from the Cricketer (if the Cricketer elects to give evidence) and from any witnesses that the Cricketer calls will be heard; and

8.5	submissions will be heard, including submissions as to any possible penalty.
8.6	The relevant Anti-Doping Organisation shall be entitled to attend the hearing and to present the details of their findings.

9. Deliberations

The Drugs Tribunal's hearing shall be conducted in private and only those with a legitimate interest in the outcome of the hearing shall be entitled to attend the hearing. The Drugs Tribunal's deliberations on its decision shall be conducted in private.

10. Requirements

In a case alleging an Anti-Doping Code Violation involving the presence of a Prohibited Substance or its Metabolites or Markers in a Cricket Player's Sample, each of the following elements will have to be proven (subject to Clause 1.3 of this Anti-Doping Code):-

10.1	the identity of the Cricket Player tested;
10.2	that the Sample came from such Cricket Player; and
10.3	that the Sample contained the alleged Prohibited Substance, Metabolite or Marker in such a manner as to constitute an Anti-Doping Code Violation.

11. Notification Of Decision

11.1	The decision of the Drugs Tribunal shall be advised to all relevant parties as soon as practicable after the conclusion of the hearing. Where it considers it appropriate, the Drugs Tribunal may deliver a short oral decision at the conclusion of the hearing with its reasons to be put in writing and communicated to the parties at a later date, or it may reserve its decision.
11.2	The Cricketer shall be entitled to a copy of the written decision of the Drugs Tribunal, which shall be sent to the Cricketer by CLT20 within 48 hours after it is provided to CLT20.
11.3	Where the Drugs Tribunal finds a Cricketer guilty of an offence under this Anti-Doping Code, the Cricketer shall be advised by the Drugs Tribunal of the right of appeal to the Drugs Appeal Tribunal. Such advice shall be included in the Drugs Tribunal's written decision and occur at the conclusion of the hearing if an oral decision is given.

12. Record Of Proceedings And Decision

12.1

The hearing of proceedings by the Drugs Tribunal shall be fully audio recorded. The record of the proceedings and all papers associated with the proceedings shall be held by CLT20 and shall be made available to the Cricketer and/or the Cricketer's Team and Home Board (in respect of which he is qualified to represent in International Cricket) if they so require, at the cost of the Cricketer, Team or Home Board (as the case may be).

Schedule 2

Procedure Of The Drugs Appeal Tribunal

1. Power To Regulate Own Procedure

The procedure of the Drugs Appeal Tribunal in any hearing of an appeal shall be as the particular Drugs Appeal Tribunal shall determine in each particular case, but subject to this power to regulate its own procedure it shall:-

1.1	generally conform with the procedures stated in this Schedule 2;
1.2	generally conform with the principles of natural justice as contained in the CLT20 Operational Rules in force at the time of the relevant Match and ensure that any Cricketer who has appealed a decision of a Drugs Tribunal is accorded the opportunity of being heard at the hearing of the appeal by the Drugs Appeal Tribunal; and
1.3	allow the Drugs Tribunal to attend the hearing to present the details of its findings.

2. Commencement Of Appeal

An appeal by the Cricketer shall be commenced by the lodging of a notice of appeal in writing with CLT20.

3. Notice Of Appeal

The notice of appeal described in paragraph of this Schedule shall be lodged within three (3) days after the date on which the written decision of the Drugs Tribunal appealed against is received by the Cricketer.

4. Lodge Of Appeal

An appeal shall be lodged when a notice of appeal is received by CLT20.

5. Contents Of Notice

The notice of appeal shall be in writing signed by the Cricketer lodging the appeal and shall specify:-

5.1	the name of the Cricketer lodging the appeal;
5.2	the decision appealed against;
5.3	the date of the decision appealed against; and
5.4	the specific grounds of the appeal.

Except as provided above, no specific form of notice of appeal is required.

6. Record Of Proceedings In Drugs Tribunal

Immediately upon the lodgment of the appeal, CLT20 shall make available to the Drugs Appeal Tribunal the full record of the proceedings before the Drugs Tribunal.

7. Hearing Date

The Drugs Appeals Tribunal shall convene to review the record of the proceedings, consider the notice of appeal and decide if there are reasonable grounds to appeal (i.e. new material evidence) and whether to hear additional evidence. If the Drugs Appeal Tribunal decides that a further hearing is necessary the appeal hearing shall be heard as soon as practicable after the lodgement of the appeal. The Drugs Appeal Tribunal shall set a time, date and place for the hearing of the appeal within 48 hours of the lodgement of the appeal and CLT20 shall inform the Cricketer who has lodged the appeal accordingly.

8. Deliberations

The Drugs Appeal Tribunal hearing shall be conducted in private and only those with a legitimate interest in the outcome of the hearing shall be entitled to attend the hearing. The Drugs Appeal Tribunal's deliberations on its decision shall be conducted in private.

9. Power Of Adjournment

The Drugs Appeal Tribunal shall have power to postpone or adjourn the hearing of an appeal and shall furnish reasons for the postponement or adjournment. Any adjournment must be no longer than is consistent with deciding the case fairly and expeditiously. The Drugs Appeal Tribunal shall endeavour to ensure that proceedings are not heard in the absence of the Cricketer, but nothing in this Code shall otherwise prevent the Drugs Appeal Tribunal hearing and determining proceedings in the absence of the Cricketer concerned where the Cricketer elects not to attend the hearing.

10 Representation

The Cricketer may be assisted and/or represented before the Drugs Appeal Tribunal by a representative of his choice.

11 Delivery Of Decision

The decision of the Drugs Appeal Tribunal shall be advised as soon as practicable after the conclusion of the hearing. Where it considers it appropriate, the Drugs Appeal Tribunal may deliver a short oral decision at the conclusion of the hearing with its reasons to be put in writing and communicated to the parties at a later date, or it may reserve its decision.

12 Written Decision

The Cricketer shall be entitled to a copy of the Drugs Appeal Tribunal's written decision which shall be shall be sent to the Cricketer by CLT20 within 48 hours after it is provided to CLT20 by the Drugs Appeal Tribunal.

13 Record Of Appeal Proceedings

The hearing of any appeal by a Drugs Appeal Tribunal shall be fully audio recorded. The record of proceedings and all papers produced at the hearing shall be retained by CLT20 and shall be made available to the Cricketer and/or the Cricketer's Team and Home Board (in respect of which he is qualified to represent in International Cricket) if they so require, at the cost of the Cricketer, Team or Home Board (as the case may be).

14 Court Of Law

No Cricketer or any other person subject to this Code shall be entitled to pursue any recourse in respect of a Doping matter in a court of law unless such party has first exhausted all the provisions of this Anti-Doping Code.

Schedule 3

Testing Protocol

Preamble

It is acknowledged that the relevant Anti-Doping Organisation appointed by CLT20 to conduct Testing under this Anti-Doping Code shall follow the testing protocol outlined in this Schedule 3 and CLT20 shall co-operate with the relevant Anti-Doping Organisation in accordance with this Schedule 3.

1. Definitions

1.1

In this Schedule 3, unless the context otherwise requires:-

1.1.1	"Chief Sampling Officer" means the Sampling Officer appointed and accredited by the relevant Anti-Doping Organisation to be responsible for the overseeing of the remaining Sampling Officers, the procedures used in the testing of Cricket Players, and the conduct of any other duties as determined by the relevant Anti-Doping Organisation;
1.1.2	"Sampling Officer" means a person appointed and accredited by the relevant Anti-Doping Organisation to assist in the obtaining of Samples from Cricket Players and who is under the direct control of the Chief Sampling Officer, and "Sampling Officers" shall have a corresponding meaning.

2. Testing

2.1

Cricket Players may be tested In-Competition or Out-of-Competition in accordance with the provisions of Clause 6.1 of the Anti-Doping Code.

3. The Draw During A Match

3.1	The random draw for the selection of any Cricket Players to be tested in any Match shall be made before commencement of play and conducted as follows.
3.2	The Chief Sampling Officer will arrange for the random draw to be made by the two Team managers or their delegated representatives and overseen by the fourth umpire. Each Team manager shall draw two Cricket Players of the opposition Team, or failing that, an independent person shall conduct the draw.
3.3	The Chief Sampling Officer shall provide a set of cards numbered 1 to 12 which numbers shall correspond with Team players as listed in the official match programme or official team list. The cards shall be placed so as to expose only the reverse side which is to be blank. The cards shall then be rearranged. Each Team manager shall select two cards from the other Team and sign on the reverse side of the card. Each Team manager shall also select another card and mark this with an "R" in addition to the Team manager's signature.
3.4	Subject to paragraph 5.1 of this Schedule 3, the two Cricket Players from each Team whose numbers correspond to the numbers on the cards shall undertake a test.
3.5	Notwithstanding any other provision in this paragraph 3, the relevant Anti-Doping Organisation, in consultation with CLT20, may select for Testing at any time during a Match such additional Cricket Players from either Team as the relevant Anti-Doping Organisation in its sole discretion considers appropriate providing that such selection shall be in conformity with the International Standard for Testing in force at the time of that Testing.

4. Testing During The Support Period

All Cricket Players will, at reasonable times, at training sessions and / or warm up matches during the Support Period, be subject to random testing Out-of-Competition. The provisions of the paragraphs below shall apply mutatis mutandis to such testing. A Cricketer may be tested more than once during the Support Period.

5. Responsibilities

5.1	5.1. A Sampling Officer (as appointed by the Chief Sampling Officer) shall, as soon as is reasonably practical after the conclusion of the Match, identify himself or herself to the two Cricket Players selected pursuant to clause 3 of this Schedule 3 and inform them of the requirements to submit themselves to a test. Where a Cricket Player whose name corresponds with the number selected in accordance with Paragraph 3.3 of this Schedule is seriously injured during the cricket match so as to be incapable of providing a Sample, the Cricket Player whose number corresponds with the card previously marked "R" by the Team manager shall undertake the test as the replacement for the injured Cricket Player and shall be so informed as soon as reasonably practical after the conclusion of the match in accordance with the provisions of this paragraph.
5.2	A Sampling Officer (as appointed by the Chief Sampling Officer) shall accompany each Cricket Player selected to be tested from the time the Chief Sampling Officer notifies the Cricket Player that the Cricket Player has been selected until such time as the Sample has been taken from the Cricket Player and sealed.
5.3	The selected Cricket Player must arrive at the Sample collection facility immediately after being advised that he has been selected. Notwithstanding this paragraph 5.3, should the selected Cricket Player:-

5.3.1	be required to attend a post match ceremony;
5.3.2	be required to fulfil media commitments;
5.3.3	be required to perform a cool down; or
5.3.4	be required to receive any reasonably necessary medical attention or food or drink excluding Prohibited Substances; the Cricket Player shall be entitled to arrive at the Sample collection facility within one hour of being informed of selection.

5.4	The Cricket Player should be informed by the Sampling Officer that the Cricket Player should not void urine until such time as the Cricket Player's Specimen has been taken.
5.5	The Cricket Player should be provided with sufficient liquid to enable the provision of a Specimen.

6. Sampling Room

6.1

CLT20 must ensure that a suitable sampling room is made available to the Sampling Officers. The sampling room shall consist of:-

6.1.1	a waiting area;
6.1.2	a Sample collection area;
6.1.3	a place of sufficient size to allow a Sampling Officer to directly observe a Cricket Player providing the Sample; and
6.1.4	sufficient amenities to facilitate the provision of a Sample.

6.2

Only the following persons shall be authorised to attend the sampling room:-

6.2.1	the Cricket Player;
6.2.2	an accompanying person of the Cricket Player's choice who may be a representative of the Cricket Player's Team;
6.2.3	the Chief Sampling Officer;
6.2.4	the Sampling Officer who has accompanied the Cricket Player since the Cricket Player's notification of selection; and
6.2.5	an interpreter (if required).

6.3

Any other persons shall only be authorised to enter the sampling room with the consent of the Chief Sampling Officer, such consent to be at the reasonable discretion of the Chief Sampling Officer.

Schedule 4

Logistics of Doping Control Procedure

In order to conform to regulations regarding the testing of Cricket Players at any Match, the following will take place, requiring minimal input from the CLT20 Match Coordinator (MC):

1.	Testing of two Cricket Players from each team will occur at matches randomly selected by CLT20, in consultation with the relevant Anti Doping Organisation, prior to the prior to the commencement of the Match commencement of the Match;
2.	Sampling Officers will notify MCs when they arrive at the Match venue that they are on site; and
3.	One hour before the match the MC or his or her delegate will accompany the Chief Sampling Officer to the dressing rooms where the Team Managers shall provide the MC with the completed Team sheet.

At this stage the Chief Sampling Officer and the Team Managers (or appropriate Team Officials) will make their way to the Sampling Room, sited close to the players' areas, and the draw will be conducted to identify the Cricket Players to be tested. The MC will take the completed Team sheet and make a photocopy to return to the Chief Sampling Officer after the draw.

One of the match officials must be at the draw to ensure its integrity ? the MC should fetch the 4th official from the match officials' room to assist in this process.

The MC will not be present during the draw.

At the end of the match, the Chief Sampling Officer will notify the Team Managers of the identified Cricket Players and the Sampling Officers will themselves notify the selected Cricket Playersof their selection for doping control. Ideally notification to the Cricket Players shall be as soon as they come off the pitch and before they get into the changing rooms.

The MC will take no take part in the testing procedure.

YOUR GUIDE TO CLT20